Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Renegade Researcher Says Alzheimer’s Drugs From Bristol-Myers, Pfizer May Be Unsafe Or Ineffective
Forbes
Monday, August 23, 2010 - 10:06am
tags:
Pfizer, Alzheimer's disease, Bristol-Myers Squibb, anti-amyloid, Eli Lilly
Patients Should Stay on Pfizer's Lipitor, Not Switch to Generic, Study Says
Bloomberg
Monday, August 23, 2010 - 9:29am
tags:
statins, Pfizer, cholesterol, Lipitor, generics
Once Again, Preemption Is Not A Defense For Wyeth
Pharmalot
Monday, August 23, 2010 - 9:20am
tags:
Wyeth, preemption, FDA, Redux, Pfizer
Roche to buy high-tech imaging company
Swissinfo
Monday, August 23, 2010 - 9:19am
tags:
Roche, M&A, imaging, Bioimagene
Warner Chilcott shares rise in pre-market trading after drugmaker updates on special dividend
Yahoo/AP
Monday, August 23, 2010 - 9:17am
tags:
Warner Chilcott, dividends
The Economics of Drug Discovery: 'First in Class' vs. 'Best in Class'
Seeking Alpha
Sunday, August 22, 2010 - 12:27pm
tags:
drug discovery
Lilly's Glimmers of Light Unlikely to Bring Future Growth
Seeking Alpha
Sunday, August 22, 2010 - 12:26pm
tags:
Eli Lilly, Cymbalta, Strattera
Eli Lilly Approaches One of Biotech's Steepest Patent Cliffs
Seeking Alpha
Sunday, August 22, 2010 - 12:03pm
tags:
Eli Lilly, Cymbalta, pain management, Zyprexa, Actos
Questcor Pharma: Acthar Approval Seems Likely
Seeking Alpha
Sunday, August 22, 2010 - 11:59am
tags:
Questcor Pharmaceuticals, Acthar, infantile spasms
SkyePharma regains United States marketing rights to Flutiform
PipeLine Review
Saturday, August 21, 2010 - 1:58pm
tags:
SkyePharma, Flutiform, asthma
TIME: Glaxo Knew of Avandia Heart Attack Risk
Lawyers and Settlements
Saturday, August 21, 2010 - 1:56pm
tags:
GSK, Avandia, legal
Aurobindo Pharma gets US FDA's nod for Ampicillin injection
The Economic Times, India
Saturday, August 21, 2010 - 1:54pm
tags:
Aurobindo, Ampicillin injection
US FDA committee recommends expanded approval for Eli Lilly's Cymbalta to a broader pain population
Pharmabiz
Saturday, August 21, 2010 - 1:51pm
tags:
Eli Lilly, Cymbalta, pain management
Regenerative medicine gets on a profitable roll
Mass High Tech
Saturday, August 21, 2010 - 1:48pm
tags:
regenerative medicine, Cell Therapy Group, Apligraf
J&J: Bond or Stock
Yahoo/Morningstar
Saturday, August 21, 2010 - 1:44pm
tags:
JNJ
EntreMed gets notice of Nasdaq violation
Yahoo/AP
Saturday, August 21, 2010 - 1:39pm
tags:
EntreMed, investors
Panel Slams ‘Date Rape’ Drug For Fibromyalgia
Forbes
Saturday, August 21, 2010 - 1:37pm
tags:
Jazz Pharmaceuticals, Rekinla, fibromyalgia
Celgene's Revlimid Marches on
Yahoo/Zacks
Saturday, August 21, 2010 - 1:35pm
tags:
Celgene, Revlimid, Multiple Myeloma
Repros stock gets boost on analyst upgrade
bizjournals.com
Saturday, August 21, 2010 - 1:31pm
tags:
Repros Therapeutics, Androxal, testosterone
Dividends Aren't Enough: Biotech
Motley Fool
Saturday, August 21, 2010 - 10:48am
tags:
Gilead Sciences, Amgen, Genzyme, Dendreon, Biogen Idec

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.